| RS5030818 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030819 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030820 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Pheochromocytoma |
| RS5030821 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030822 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Chuvash polycythemia |
| RS5030823 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Von Hippel-Lindau syndrome |
| RS5030825 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Von Hippel-Lindau syndrome |
| RS5030826 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030827 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030829 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030830 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Chuvash polycythemia |
| RS5030832 |
VHL
|
Health Risk |
Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030833 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Von Hippel-Lindau syndrome |
| RS5030835 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030841 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS5030842 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS5030843 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, PAH-related disorder |
| RS5030844 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS5030845 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS5030846 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS5030847 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, See cases |
| RS5030848 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS5030849 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, PAH-related disorder |
| RS5030850 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Pulmonary hypertension |
| RS5030851 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS5030852 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Hyperphenylalaninemia |
| RS5030853 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Hyperphenylalaninemia |
| RS5030854 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS5030855 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS5030856 |
PAH
|
Health Risk |
Pathogenic |
Hyperphenylalaninemia, Phenylketonuria |
| RS5030857 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS5030858 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, PAH-related disorder |
| RS5030859 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, PAH-related disorder |
| RS5030860 |
PAH
|
Health Risk |
Pathogenic |
Hyperphenylalaninemia, Phenylketonuria |
| RS5030861 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS5030868 |
G6PD
|
Health Risk |
Pathogenic/Likely pathogenic |
G6PD MEDITERRANEAN, G6PD CAGLIARI |
| RS5030869 |
G6PD
|
Health Risk |
Pathogenic |
G6PD CHATHAM, Anemia |
| RS5030872 |
G6PD
|
Health Risk |
Pathogenic/Likely pathogenic |
G6PD MALAGA, Anemia |
| RS5030952 |
CAPN10
|
Health Risk |
risk factor |
Type 2 diabetes mellitus 1, susceptibility to |
| RS5031012 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS5038 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic anemia, Autosomal dominant distal renal tubular acidosis |
| RS5041 |
AGT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS505058 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hutchinson-Gilford syndrome, Lethal tight skin contracture syndrome |
| RS507666 |
ABO
|
Health Risk |
association |
ABO blood group system, ABO blood group system |
| RS509504 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS513699 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 4, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS515726060 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS515726063 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726065 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS515726067 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726071 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726072 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726073 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726075 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726081 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726083 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS515726085 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726088 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726094 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726099 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726103 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726104 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726108 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726111 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726113 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726114 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group N |
| RS515726116 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726117 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726118 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS515726122 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726123 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726125 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726126 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726127 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS515726130 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS515726131 |
CLCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
EPILEPSY, JUVENILE MYOCLONIC |
| RS515726134 |
BBIP1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 18 |
| RS515726135 |
LZTFL1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 17 |
| RS515726136 |
LZTFL1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 17 |
| RS515726137 |
ATP8B1
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 1, Inborn genetic diseases |
| RS515726141 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, SAMHD1-related disorder |
| RS515726143 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS515726145 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Inborn genetic diseases |
| RS515726146 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS515726147 |
ABCB7
|
Health Risk |
Pathogenic |
X-linked sideroblastic anemia with ataxia, X-linked sideroblastic anemia with ataxia |
| RS515726148 |
APOE
|
Health Risk |
Pathogenic |
Sea-blue histiocyte syndrome, Cardiovascular phenotype |
| RS515726149 |
PIK3R1
|
Health Risk |
Conflicting classifications of pathogenicity |
SHORT syndrome, SHORT syndrome |
| RS515726153 |
TRPV4
|
Health Risk |
Pathogenic |
Skeletal dysplasia, Metatropic dysplasia |
| RS515726154 |
TRPV4
|
Health Risk |
Pathogenic/Likely pathogenic |
Skeletal dysplasia, Skeletal dysplasia and progressive central nervous system degeneration |
| RS515726162 |
TRPV4
|
Health Risk |
Pathogenic/Likely pathogenic |
Skeletal dysplasia, Charcot-Marie-Tooth disease axonal type 2C |
| RS515726163 |
TRPV4
|
Health Risk |
Pathogenic |
Skeletal dysplasia, Metatropic dysplasia |
| RS515726166 |
TRPV4
|
Health Risk |
Pathogenic |
Neuromuscular disease, Skeletal dysplasia |
| RS515726170 |
TRPV4
|
Health Risk |
Pathogenic |
Familial digital arthropathy-brachydactyly, Familial digital arthropathy-brachydactyly |
| RS515726172 |
TRPV4
|
Health Risk |
Likely pathogenic |
Skeletal dysplasia, Skeletal dysplasia |
| RS515726173 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS515726175 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS515726177 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS515726180 |
RRM2B
|
Health Risk |
Pathogenic/Likely pathogenic |
RRM2B-related mitochondrial disease, Mitochondrial disease |
| RS515726181 |
RRM2B
|
Health Risk |
Pathogenic/Likely pathogenic |
RRM2B-related mitochondrial disease, Mitochondrial DNA depletion syndrome 8a |
| RS515726183 |
RRM2B
|
Health Risk |
Likely pathogenic |
— |